Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

Biotx.ai is an AI-driven causal modeling company focused on drug discovery and development. They leverage a proprietary causal genome dataset to map genomic loci to downstream effects on biomarker…

Biotx.ai is an AI-driven causal modeling company focused on drug discovery and development. They leverage a proprietary causal genome dataset to map genomic loci to downstream effects on biomarker…
Focus: AI-driven causal modeling for drug discovery and biomarker-led precision medicine
Headquarters: Potsdam/Berlin, Germany
Founding year: 2017
Notable capabilities: Large-scale Mendelian randomization, colocalization, synthetic clinical trials using ~2M genomes (company claim)
Team / leadership: Founder: Jörn Klinger; Senior leader: Marco Schmidt
Drug discovery, target validation, biomarker discovery, and clinical-trial design using causal genomics and AI.
2017
Biotechnology
Company reports project-level and regional/EU grant support (European Regional Development Fund and related Brandenburg/ESF programs) rather than disclosed venture rounds.
“Harald Pinger identified as first major investor; Hoxton Ventures represented on board via Hussein Kanji; additional investors listed in profiles include Oxonian Ventures and PROTOCOL.”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
60,000+
Open Roles
200+
New This Week